Evidence map›Paper›PMID 25505331›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2014

Antigen dependently activated cluster of differentiation 8-positive T cells cause perforin-mediated neurotoxicity in experimental stroke.

Eva Mracsko, Arthur Liesz, Ana Stojanovic, Wilson Pak-Kin Lou, Matthias Osswald, Wei Zhou, Simone Karcher, Frank Winkler, Ana Martin-Villalba, Adelheid Cerwenka and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 114 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Semaglultide targets Spp1Journal of neuroinflammation · 2025
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Eva MracskoDepartment of Neurology, University of Heidelberg, D-69120 Heidelberg, Germany.
Arthur LieszDepartment of Neurology, University of Heidelberg, D-69120 Heidelberg, Germany, Institute for Stroke and Dementia Research, Munich University Hospital, D-81377 Munich, Germany, Munich Cluster for Systems Neurology (SyNergy), D-80336 Munich, Germany, Groups.
Ana StojanovicInnate Immunity and.
Wilson Pak-Kin LouMolecular Neurobiology and.
Matthias OsswaldClinical Cooperation Unit Neurooncology, German Cancer Research Center, D-69120 Heidelberg, Germany, Department of Neurooncology at the National Center for Tumor Diseases, University Hospital Heidelberg, D-69120 Heidelberg, Germany, and.
Wei ZhouDepartment of Neurology, University of Heidelberg, D-69120 Heidelberg, Germany.
Simone KarcherDepartment of Neurology, University of Heidelberg, D-69120 Heidelberg, Germany.
Frank WinklerClinical Cooperation Unit Neurooncology, German Cancer Research Center, D-69120 Heidelberg, Germany, Department of Neurooncology at the National Center for Tumor Diseases, University Hospital Heidelberg, D-69120 Heidelberg, Germany, and.
Ana Martin-VillalbaMolecular Neurobiology and.
Adelheid CerwenkaInnate Immunity and.
Roland VeltkampDepartment of Neurology, University of Heidelberg, D-69120 Heidelberg, Germany, Division of Brain Sciences, Imperial College London, SW7 2AZ London, United Kingdom Roland.Veltkamp@med.uni-heidelberg.de.
Heidelberg University · DEInnate Pharma (France) · FRInstitute of Neurobiology and Molecular Medicine · ITGerman Cancer Research Center · DENational Center for Tumor Diseases · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroinflammation plays a key role in secondary brain damage after stroke. Although deleterious effects of proinflammatory cytokines are well characterized, direct cytotoxic effects of invading immune cells on the ischemic brain and the importance of their antigen-dependent activation are essentially unknown. Here we examined the effects of adaptive and innate immune cells-cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells-that share the direct perforin-mediated cytotoxic pathway on outcome after cerebral ischemia in mice. Although CTLs and NK cells both invaded the ischemic brain, only brain-infiltrating CTLs but not NK cells were more activated than their splenic counterparts. Depletion of CTLs decreased infarct volumes and behavioral deficit in two ischemia models, whereas NK cell depletion had no effect. Correspondingly, adoptive CTL transfer from wild-type into Rag1 knock-out mice increased infarct size. Adoptive CTL transfer from perforin knock-out or interferon-γ knock-out mice into Rag1 knock-out mice revealed that CTL neurotoxicity was mediated by perforin. Accordingly, CTLs isolated from wild-type or interferon-γ knock-out but not from perforin knock-out mice induced neuronal cell death in vitro. CTLs derived from ovalbumin-specific T-cell receptor transgenic mice were not activated and infiltrated less into the ischemic brain compared with wild-type CTLs. Their transfer did not increase the infarct size of Rag1 knock-out mice, indicating antigen-dependent activation as an essential component of CTL neurotoxicity. Our findings underscore the importance of antigen-dependent, direct cytotoxic immune responses in stroke and suggest modulation of CTLs and their effector pathways as a potential new strategy for stroke therapy.

Indexed as

Disease Models, AnimalAnimalsAntigens, CDCD8-Positive T-LymphocytesCytotoxinsMaleMiceMice, Inbred C57BLMice, KnockoutPerforinStrokeAntigens, CDCytotoxinsPerforincytotoxic T lymphocytesischemic strokeNK cellsperforin

Identifiers

PMID25505331
PMCPMC6608504
OpenAlexW2056973477

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.